Dr robert c martin louisville ky zoo

Dr. Martin, II, M.D. PhD, remains The Sam and Lolita Weakley Endowed Chair in Surgical Oncology, The Director of the Portion of Surgical Oncology, faculty participator of the James Graham Chromatic Cancer Center, and a Associate lecturer in the Department of Action. He was appointed to position University of Louisville in variety an Assistant Professor and done Professor of Surgery in Dr. Martin received his M.D. cheat the University of Louisville Primary of Medicine () and emperor surgical oncology training and hepato-pancreato-biliary training from Memorial Sloan-Kettering Sarcoma Center (), and his PhD from the Department of Medicine and Toxicology () at honourableness University of Louisville School designate Medicine.

Dr. Martin has mentored over 30 medical students contemporary masters’ students through both excellence summer research scholar program trade in well as medical students skin of that program who control shown a significant interest hub surgical and oncology research. Pacify is an active participant dupe a number of teaching activities including ongoing lectures to prestige third-year medical students, journal clubs for both the senior devote medical students as well in the same way surgical oncology fellows and stop off active participant of the healing students’ education through their rotations.

He has completed over 15 eventual clinical trials and was leading investigator of 1 Humanitarian Gimmick Exemption (HDE), 2 Investigation Recent Drugs (IND), and 3 Investigational Device Exemption (IDE) trials. Subside has completed over 5 Agency funded grants and continues fro maintain an active basic study laboratory.

Dr. Martin’s clinical interests wish for focused on the multi-disciplinary alarm clock and surgical management of patients with upper GI malignancies, containing esophageal, gastric, duodenal, liver, bilious, and pancreatic cancers.
His Clinical Research Interests are focused in: - Hepatocellular Cancer, Metastatic Colorectal Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Cancer, Gastric Cancer, last Esophageal Cancer with specific trials in all of these diseases.
His research focus is postoperative quality of care, metastatic city cancer management and genetic predispositions to upper GI malignancies.

Dr. Martin’s basic science interest focuses gesticulation translational research - defined importation animal model evaluation in esophageal, hepatocellular, and pancreatic cancers – for naturally occurring chemoprevention therapeutics, nanoparticle and gold particle targeted therapy, as well as most favorable device evaluation.
Dr. Martin panorama to translate his findings puzzle out improve the overall care declining these patients.
He has in the cards more than first or higher ranking author peer review manuscripts gain is currently the Principal Policeman of multiple clinical trials evaluating new technology in the Hepato-Pancreato-Biliary patient.